LifePoint Health, Inc. (NASDAQ:LPNT) – Stock analysts at KeyCorp cut their FY2017 earnings per share estimates for LifePoint Health in a research report issued to clients and investors on Sunday. KeyCorp analyst J. Gurda now anticipates that the company will post earnings per share of $3.70 for the year, down from their previous estimate of $4.11. KeyCorp currently has a “Hold” rating on the stock. KeyCorp also issued estimates for LifePoint Health’s FY2018 earnings at $4.17 EPS and FY2019 earnings at $4.70 EPS.
Several other research firms also recently weighed in on LPNT. SunTrust Banks, Inc. set a $60.00 price target on LifePoint Health and gave the company a “hold” rating in a research note on Thursday, October 12th. BMO Capital Markets started coverage on LifePoint Health in a research note on Monday, October 16th. They set a “market perform” rating and a $59.00 price target on the stock. ValuEngine upgraded LifePoint Health from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. Raymond James Financial, Inc. reissued a “market perform” rating on shares of LifePoint Health in a report on Monday. Finally, Robert W. Baird set a $55.00 price objective on LifePoint Health and gave the company a “buy” rating in a report on Monday. Three equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $60.57.
WARNING: This article was posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.com-unik.info/2017/11/01/fy2017-earnings-estimate-for-lifepoint-health-inc-lpnt-issued-by-keycorp.html.
LifePoint Health (NASDAQ:LPNT) opened at 48.15 on Tuesday. LifePoint Health has a one year low of $46.50 and a one year high of $70.95. The company has a market capitalization of $1.93 billion, a P/E ratio of 10.78 and a beta of 0.84. The stock’s 50 day moving average price is $56.01 and its 200-day moving average price is $60.23.
LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings results on Friday, October 27th. The company reported $0.80 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.15). The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.60 billion. LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The company’s revenue for the quarter was down .7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.94 earnings per share.
A number of large investors have recently bought and sold shares of LPNT. Principal Financial Group Inc. increased its stake in LifePoint Health by 1.9% during the 1st quarter. Principal Financial Group Inc. now owns 163,064 shares of the company’s stock worth $10,681,000 after buying an additional 2,992 shares in the last quarter. Legal & General Group Plc increased its stake in LifePoint Health by 30.4% during the 1st quarter. Legal & General Group Plc now owns 57,028 shares of the company’s stock worth $3,736,000 after buying an additional 13,304 shares in the last quarter. Thrivent Financial For Lutherans increased its stake in LifePoint Health by 9.2% during the 1st quarter. Thrivent Financial For Lutherans now owns 7,570 shares of the company’s stock worth $496,000 after buying an additional 640 shares in the last quarter. Vanguard Group Inc. increased its stake in LifePoint Health by 3.8% during the 1st quarter. Vanguard Group Inc. now owns 3,266,963 shares of the company’s stock worth $213,986,000 after buying an additional 120,201 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in LifePoint Health by 4.9% during the 1st quarter. Geode Capital Management LLC now owns 330,096 shares of the company’s stock worth $21,620,000 after buying an additional 15,276 shares in the last quarter. Institutional investors own 99.53% of the company’s stock.
LifePoint Health announced that its board has approved a stock buyback program on Friday, October 27th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s management believes its shares are undervalued.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
What are top analysts saying about LifePoint Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LifePoint Health Inc. and related companies.